Year |
Citation |
Score |
2020 |
Chew CAZ, Tay LM, Hooi L, Chow EK, Bonney GK, Chan SL. Abstract 3929: Patient-derived pancreatic cancer organoids as in-vitro cancer models for personalizing therapy Cancer Research. 80: 3929-3929. DOI: 10.1158/1538-7445.Am2020-3929 |
0.304 |
|
2015 |
Ho D, Wang CK, Chow EK. Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine. Science Advances. 1: e1500439. PMID 26601235 DOI: 10.1126/Sciadv.1500439 |
0.305 |
|
2014 |
Toh TB, Lee DK, Hou W, Abdullah LN, Nguyen J, Ho D, Chow EK. Nanodiamond-mitoxantrone complexes enhance drug retention in chemoresistant breast cancer cells. Molecular Pharmaceutics. 11: 2683-91. PMID 24867631 DOI: 10.1021/Mp5001108 |
0.302 |
|
2014 |
Chow EK. TRAIL-Blazing Therapy Against Circulating Tumor Cells Science Translational Medicine. 6: 221ec18-221ec18. DOI: 10.1126/Scitranslmed.3008472 |
0.305 |
|
2013 |
Abdullah LN, Chow EK. Mechanisms of chemoresistance in cancer stem cells. Clinical and Translational Medicine. 2: 3. PMID 23369605 DOI: 10.1186/2001-1326-2-3 |
0.302 |
|
2012 |
Chow EK. Implication of cancer stem cells in cancer drug development and drug delivery. Journal of Laboratory Automation. 18: 6-11. PMID 22893634 DOI: 10.1177/2211068212454739 |
0.311 |
|
2011 |
Ghaffari AA, Chow EK, Iyer SS, Deng JC, Cheng G. Polyinosinic-polycytidylic acid suppresses acetaminophen-induced hepatotoxicity independent of type I interferons and toll-like receptor 3. Hepatology (Baltimore, Md.). 53: 2042-52. PMID 21433044 DOI: 10.1002/Hep.24316 |
0.539 |
|
2009 |
Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY, Belperio JA, Cheng G, Deng JC. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. The Journal of Clinical Investigation. 119: 1910-20. PMID 19487810 DOI: 10.1172/Jci35412 |
0.719 |
|
2008 |
Chow EK, Pierstorff E, Cheng G, Ho D. Copolymeric nanofilm platform for controlled and localized therapeutic delivery. Acs Nano. 2: 33-40. PMID 19206545 DOI: 10.1021/Nn7000917 |
0.495 |
|
2007 |
Chow EK, Razani B, Cheng G. Innate immune system regulation of nuclear hormone receptors in metabolic diseases. Journal of Leukocyte Biology. 82: 187-95. PMID 17314330 DOI: 10.1189/Jlb.1206741 |
0.702 |
|
2007 |
CHOW EK, CHU B, CHENG G, TAI Y, PIERSTORFF E, HO D. COPOLYMER-MEDIATED FABRICATION OF VERSATILE ELECTRO-ACTIVE AND INFLAMMATION ATTENUATING SUBSTRATES FOR BIOLOGICAL INTERROGATION Nano. 2: 351-359. DOI: 10.1142/S1793292007000696 |
0.473 |
|
2007 |
Chow EK, Pierstorff E, Cheng G, Tai YC, Ho D. Attenuation of cellular inflammation using glucocorticoid-functionalized copolymers Proceedings of the 2nd Ieee International Conference On Nano/Micro Engineered and Molecular Systems, Ieee Nems 2007. 1039-1043. DOI: 10.1109/NEMS.2007.352195 |
0.427 |
|
2006 |
Chow EK, Castrillo A, Shahangian A, Pei L, O'Connell RM, Modlin RL, Tontonoz P, Cheng G. A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections. The Journal of Experimental Medicine. 203: 2589-602. PMID 17074929 DOI: 10.1084/Jem.20060929 |
0.727 |
|
2005 |
Chow EK, O'connell RM, Schilling S, Wang XF, Fu XY, Cheng G. TLR agonists regulate PDGF-B production and cell proliferation through TGF-beta/type I IFN crosstalk. The Embo Journal. 24: 4071-81. PMID 16308570 DOI: 10.1038/Sj.Emboj.7600867 |
0.649 |
|
2004 |
Perry AK, Chow EK, Goodnough JB, Yeh WC, Cheng G. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. The Journal of Experimental Medicine. 199: 1651-8. PMID 15210743 DOI: 10.1084/Jem.20040528 |
0.552 |
|
2004 |
Doyle SE, O'Connell RM, Miranda GA, Vaidya SA, Chow EK, Liu PT, Suzuki S, Suzuki N, Modlin RL, Yeh WC, Lane TF, Cheng G. Toll-like receptors induce a phagocytic gene program through p38. The Journal of Experimental Medicine. 199: 81-90. PMID 14699082 DOI: 10.1084/Jem.20031237 |
0.741 |
|
2003 |
Doyle SE, O'Connell R, Vaidya SA, Chow EK, Yee K, Cheng G. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4. Journal of Immunology (Baltimore, Md. : 1950). 170: 3565-71. PMID 12646618 DOI: 10.4049/Jimmunol.170.7.3565 |
0.739 |
|
Show low-probability matches. |